Transurethral Balloon Dilatation Of Prostate Research Articles

AB001. Transurethral balloon dilatation of prostate in treatment of patients with benign prostatic hyperplasia

Benign prostatic hyperplasia (BPH) is a benign hyperplasia of prostate gland cells of the urethra affecting increasing population. The most common method of treatment is transurethral resection of the prostate (TURP). But many complications may occur including intraoperative or postoperative hemorrhage, prostate perforation, urinary incontinence and bladder neck contracture. Transurethral balloon dilatation of prostate (TUDP) is a safe and simple method of treating BPH. It can be performed as outpatient operation and using topical anesthesia and sedation. TUDP can shorten the time of urethral catheterization. We can conclude that TUDP is an effective and economic way in treating BPH, while the long term efficacy remains to be observed.

One-year effect of ultrasound guided transurethral balloon dilation of prostate for the treatment of benign prostatic hyperplasia

Objective To investigate the efficacy and safety of transrectal ultrasound guided transurethral balloon dilation of the prostate (TUDP) for the treatment of benign prostatic hyperplasia (BPH).Methods A total of 23 men with BPH who had undergone TUDP were retrospectively analyzed,including 16 men with indwelling urinary catheters before the operation.During the TUDP,the prostatic apex and membranous urethra were dilated by inner balloon,and the prostatic urethra and bladder neck were dilated by outer balloon.The patients were followed up at the 1st,3rd,6th and 12th month after the operation,and the observation parameters included subjective symptoms,such as international prostatic symptom score (IPSS) and quality of life (QOL) score,and objective parameters,such as maximum flow rate (Qmax) and post-void residual (PVR).Results The operation time was 30-165 min,and the intraoperative hemorrhage volume was 5-50 ml.The IPSS scores at 1st,3rd,6th and 12th month after the operation were 10.4± 4.2,8.7±3.2,9.5±4.6 and 8.3±1.5 respectively,which were significantly decreased in comparison to the IPSS score (22.0±7.2) before the operation (P＜0.05).The QOL scores at 1st,3rd,6th and 12th month after the operation were 2.1±1.1,1.6±1.0,1.8±1.1 and 1.6±1.0 respectively,which were significantly improved in comparison to the QOL score (4.9±0.9) before the operation (P＜0.05).The Qmax at 1st,3rd,6th and 12th month after the operation were (10.5±3.4),(12.4±4.2),(10.9±3.9) and (12.7±4.6) ml/s respectively,which were significantly increased in comparison to the Qmax(1.9± 1.9 ml/s) before the operation (P＜0.05).There were 5,4,2 cases of urinary incontinence at the 1st,2nd and 3rd month after the operation,but they recovered at the 4th month follow-up.Besides,there were 3 cases suffered from epididymitis.Conclusion Transrectal ultrasound guided TUDP is a safe,effective and cheap option for the treatment of BPH,especially for the primary hospitals. Key words: Ultrasound guided; Transurethral balloon dilatation of the prostate; Prostatic hyperplasia; Treatment outcome

Retrograde transurethral balloon dilation of prostate: Innovative management of abacterial chronic prostatitis and prostatodynia

Retrograde transurethral balloon dilatation (RTBD) of the prostate recently has beensuggested as alternative therapy for patients with benign prostatie hyperplasia (BPH). Seven patients with documented functional urinary outlet obstruction at the level of the bladder neck or prostatie urethra underwent RTBD of prostate. Each patient had a classic diagnosis of abacterial chronic prostatitis or prostatodynia based on history, physical examination, and localization cultures. Prior to RTBD of prostate, patients underwent cystoseopy, voiding eystourethrogram, urodynamic and uroflow studies. RTBD of prostate was done as an outpatient procedure requiring intravenous sedation or general anesthesia. Dilation was performed with a 25-mm urethroplasty balloon catheter inflated at 3.5 atm of pressure for twenty minutes. Improvement in voiding symptomatology was noted in all patients and graded numerically (0–10 scale), with ten indicating normal voiding. Follow-up to date ranges from one to five months. This technique may have promise as a treatment option in patients with abacterial chronic prostatitis and prostatodynia.

Transurethral Balloon Dilatation of Prostate for Prostatism: Preliminary Report of Nonsurgical Technique

Ten men with symptomatic benign prostatic hyperplasia underwent transurethral balloon dilatation under sedation and topical anesthesia. There were no complications. Relief of symptoms and an improvement in urine flow occurred in six men. Balloon dilatation was repeated in two of the four failures without effect. The mechanism of improvement in the successful cases is not clear.